Harmony Biosciences Holdings, Inc.
HRMY
$38.12
-$0.38-0.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 181.27M | 145.62M | 158.69M | 185.68M | 180.90M |
| Total Depreciation and Amortization | 25.34M | 25.34M | 25.34M | 23.87M | 23.87M |
| Total Amortization of Deferred Charges | 616.00K | 632.00K | 647.00K | 659.00K | 673.00K |
| Total Other Non-Cash Items | 89.06M | 102.34M | 71.71M | 53.81M | 38.77M |
| Change in Net Operating Assets | 58.80M | 68.05M | 91.82M | 33.60M | 15.16M |
| Cash from Operations | 355.08M | 341.97M | 348.20M | 297.61M | 259.38M |
| Capital Expenditure | -178.00K | -182.00K | -310.00K | -716.00K | -648.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -337.39M | -225.48M | -39.34M | -28.49M | -23.02M |
| Cash from Investing | -337.57M | -225.66M | -39.65M | -29.20M | -23.67M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -18.75M | -17.50M | -16.25M | -15.00M | -15.00M |
| Issuance of Common Stock | 9.27M | 5.85M | 10.21M | 10.79M | 12.62M |
| Repurchase of Common Stock | -4.30M | -4.26M | -3.00M | -4.57M | -4.57M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.79M | -15.92M | -9.05M | -8.78M | -6.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.72M | 100.40M | 299.50M | 259.63M | 228.75M |